In vitro effects of lapachol and β-lapachone against Leishmania amazonensis

In vitro effects of lapachol and β-lapachone against Leishmania amazonensis

Leishmaniasis is a neglected disease that affects millions of people worldwide, and special attention should be given to treatment because the available drugs have limitations, which can lead to low therapeutic adherence and parasitic resistance. This study evaluated the activity of the bioactive na...

Full description

Bibliographic Details
Main Authors:	Á.C.F.H. Ramos-Milaré, B.G. Sydor, A.Á. Brustolin, D.S.S.L. Lera-Nonose, J. Oyama, E.L. Silva, W. Caetano, K.S.S. Campanholi, I.G. Demarchi, T.G.V. Silveira, M.V.C. Lonardoni
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2023-05-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Leishmaniasis Cutaneous leishmaniasis Leishmania Naphthoquinones Natural products
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2023000100635&lng=en&tlng=en

Similar Items

Epoxy-α-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2H-naphtho[2,3-b]pyran-10,2′-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites
by: Juliana Figueiredo Peixoto, et al.
Published: (2023-03-01)

American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case
by: Jully Oyama, et al.
Published: (2018-02-01)

Antileishmanial activity of lapachol analogues
by: Nadja MF Lima, et al.
Published: (2004-11-01)

In Vitro Evaluation of the Combinatorial Effect of Naringenin and Miltefosine against <i>Leishmania amazonensis</i>
by: Vinícius Lopes Lessa, et al.
Published: (2024-08-01)

In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches
by: Lina S. Prieto Cárdenas, et al.
Published: (2022-05-01)

Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes
by: Fernanda de Aquino Marinho, et al.
Published: (2011-06-01)

Interleukin- 2 production during murine infection by Leishmania mexicana amazonensis
by: Manoel Barral-Netto, et al.
Published: (1986-03-01)

Effects of Brazilian propolis on Leishmania amazonensis
by: Diana Copi Ayres, et al.
Published: (2007-03-01)

Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis
by: Juliana Figueiredo Peixoto, et al.
Published: (2024-04-01)

Atividade leishmanicida de extrato hidroalcoólico de própolis brasileira em Leishmania amazonensis
by: Suelen Santos da Silva, et al.
Published: (2015-12-01)

Clinical, laboratory, and therapeutic characteristics of American tegumentary leishmaniasis in the 15 th State Health Division, Northwest Paraná State, Southern Brazil
by: Priscila Wolf Nassif, et al.

Efficacy of a diarylheptanoid derivative against Leishmania amazonensis
by: Alves Luciana Vignólio, et al.
Published: (2003-01-01)

Rapid Clinical Management of Leishmaniasis in Emergency Department: A Case Report with Clinical Review of Recent Literature
by: Andrea Piccioni, et al.
Published: (2020-10-01)

Vaccination with Formulation of Nanoparticles Loaded with <i>Leishmania amazonensis</i> Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster
by: Marco Antonio Cabrera González, et al.
Published: (2023-01-01)

Tegumentary leishmaniasis mimicking visceralization in a cirrhotic patient: atypical cutaneous lesions and local immunological features
by: Sebastian Vernal, et al.
Published: (2020-01-01)

A Review of the Progress in the Development of Leishmaniasis Vaccines
by: Narges Khaghanzadeh, et al.
Published: (2024-07-01)

Unusual Observations in Leishmaniasis—An Overview
by: Priya Yadav, et al.
Published: (2023-02-01)

Leishmania tropica infection in wild and domestic canines
by: G Baneth, et al.
Published: (2014-04-01)

Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal leishmaniasis refractory to antimony: a case report
by: Badaro Roberto, et al.
Published: (2001-01-01)

Update in the treatment of cutaneous leishmaniasis
by: Sahar H Al-Natour
Published: (2009-01-01)

Tegumentary leishmaniasis in Northern Argentina: distribution of infection and disease, in three municipalities of Salta, 1990-1992
by: Sosa-Estani Sergio, et al.
Published: (2000-01-01)

Canine visceral leishmaniasis in area with recent Leishmania transmission: prevalence, diagnosis, and molecular identification of the infecting species
by: Josiane Valadão Lopes, et al.
Published: (2020-09-01)

Impact of leishmaniasis on public health
by: L. B Camargo, et al.
Published: (2006-01-01)

Estudo comparativo entre miltefosina oral e antimoniato de N-metil glucamina parenteral no tratamento da leishmaniose experimental causada por Leishmania (Leishmania) amazonensis Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis
by: Arnoldo Velloso da Costa Filho, et al.
Published: (2008-08-01)

In vitro activity of the hydroethanolic extract and biflavonoids isolated from Selaginella sellowii on Leishmania (Leishmania) amazonensis
by: Yasmin Silva Rizk, et al.
Published: (2014-12-01)

Retrospective Analysis of Leishmaniasis in Sicily (Italy) from 2013 to 2021: One-Health Impact and Future Control Strategies
by: Federica Bruno, et al.
Published: (2022-08-01)

American tegumentary leishmaniasis: epidemiological and molecular characterization of prevalent Leishmania species in the State of Tocantins, Brazil, 2011-2015
by: Carina Scolari Gosch, et al.
Published: (2017-12-01)

Brief communication: Vitamin D serum levels in American tegumentary leishmaniasis from an endemic area in Northeast Brazil
by: Lorena Pinheiro Figueiredo, et al.
Published: (2023-01-01)

Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil
by: Sebastian Vernal, et al.
Published: (2019-04-01)

Acrylonitrile derivatives: In vitro activity and mechanism of cell death induction against Trypanosoma cruzi and Leishmania amazonensis
by: Carlos J. Bethencourt-Estrella, et al.
Published: (2024-04-01)

Inefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensis
by: R. N. R. Sampaio, et al.
Published: (2007-01-01)

Isolation of Leishmania sp. from aqueous humor of a patient with cutaneous disseminated leishmaniasis and bilateral iridocyclitis (preliminary report) Isolamento de Leishmania sp a partir do humor aquoso de paciente portador de Leishmaniose cutânea disseminada e iridociclite bilateral (nota prévia)
by: Teresa Cristina de Abreu Ferrari, et al.
Published: (1990-08-01)

High Selectivity of 8-Hydroxyquinoline on <i>Leishmania (Leishmania)</i> and <i>Leishmania (Viannia)</i> Species Correlates with a Potent Therapeutic Activity In Vivo
by: Sarah Kymberly Santos de Lima, et al.
Published: (2023-05-01)

Efficacy and safety of a single dose pentamidine (7mg/kg) for patients with cutaneous leishmaniasis caused by L. guyanensis: a pilot study
by: Ellen Priscilla Nunes Gadelha, et al.
Published: (2015-12-01)

Lupoid Cutaneous Leishmaniasis: Review
by: Maryam Amin Moghadam, et al.
Published: (2016-07-01)

Complicación mucosa de la leishmaniasis cutánea
by: Diego Fernando Zea, et al.
Published: (2009-03-01)

Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis
by: Jéssica Adriana Jesus, et al.
Published: (2020-10-01)

Detection and activity of MMP-2 and MMP-9 in Leishmania amazonensis and Leishmania braziliensis promastigotes
by: Brenda Furtado Costa, et al.
Published: (2023-08-01)

The role of complement in the early phase of Leishmania (Leishmania) amazonensis infection in BALB/c mice
by: M.D. Laurenti, et al.
Published: (2004-03-01)

Host cholesterol influences the activity of sterol biosynthesis inhibitors in Leishmania amazonensis
by: Valter Viana Andrade-Neto, et al.
Published: (2022-04-01)